2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Wednesday, September 25, 2019

1:15pm-2:45pm: Predicting the functional impact on the performance of daily activities in people with PD: a novel approach based on objective measures obtained by inertial sensors

K. Lebel, C. Duval, E. Goubault, S. Bogard, P. Blanchet (Montreal, QC, Canada)

Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3

1:15pm-2:45pm: Predictors of Orthostatic Hypotension in Patients with Parkinson’s Disease

C-C. Lin, J. Heisler, H. Patel, W. Ondo (Houston, TX, USA)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Predictors of refractory impulse control disorder to dopamine agonists substitution therapy in Parkinson’s disease patients

JY. Lee, J-H. Choi, B. Jeon, J. Cho (Seoul, Republic of Korea)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Preoperative Smoking History Increases Risk of Infection in Deep Brain Stimulation Surgery

M. Sikora, F. Farrokhi, M. Marsans, S. Monsell, A. Wright, M. Palmer, A. Hoefer, P. Mcleod, J. Mark, J. Carlson (Seattle, WA, USA)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: Preoperative stratification of gait outcome from subthalamic nucleus stimulation

I. Cebi, M. Scholten, A. Gharabaghi, D. Weiss (Tubingen, Germany)

Surgical Therapy · Les Muses Terrace, Level 3

1:15pm-2:45pm: Preserved white matter microstructure in Parkinson’s disease patients with levodopa-induced dyskinesia: Evaluation by neurite orientation dispersion and density imaging (NODDI)

T. Ogawa, T. Hatano, H. Takeshige, C. Andica, K. Kamagata, A. Saito, T. Koinuma, R. Nakamura, H. Iwamuro, G. Oyama, Y. Shimo, A. Umemura, M. Ito, S. Aoki, N. Hattori (Tokyo, Japan)

Neuroimaging · Les Muses Terrace, Level 3

1:15pm-2:45pm: Prevalence and associated risk factors of early morning off among the patients with Parkinson’s disease in China

W. Mao, C. Han, J. An, Z. Liu, P. Chan (Beijing, China)

Phenomenology and Clinical Assessment of Movement Disorders · Les Muses Terrace, Level 3

1:15pm-2:45pm: Prevalence and clinical characteristics of Parkinson Disease in Chernivtsi Region of Ukraine

O. Yaremchuk, I. Yaremchuk (Chernivtsi, Ukraine)

Epidemiology · Les Muses, Level 3

1:15pm-2:45pm: Prevalence and factors related to orthostatic hypotension and orthostatic intolerance in recently-diagnosed, drug-naïve Parkinson’s disease patients

S. Perez-Lloret, C. Quarracino, F. Capani, M. Otero-Losada (Buenos Aires, Argentina)

Non-Motor Symptoms · Agora 3 West, Level 3

1:15pm-2:45pm: Prevalence of advanced Parkinson’s Disease in patients treated in the hospitals of the Spanish public health care system: PARADISE Study (interim analysis)

JC. Martínez-Castrillo, P. Martínez-Martín, A. Burgos, G. Arroyo, N. García, MR. Luquín, JM. Arbelo (Las Palmas, Spain)

Epidemiology · Les Muses, Level 3